Clinical impact of laboratory implementation of verigene BC-GN microarray-based assay for detection of gram-negative bacteria in positive blood cultures

Journal of Clinical Microbiology

Volumn 54, Issue 7, 2016, Pages 1789-1796

  Walker, Tamar ^a   Dumadag, Sandrea ^b   Lee, Christine Jiyoun ^b   Lee, Seung Heon ^a   Bender, Jeffrey M ^a   Abbott, Jennifer Cupo ^b   She, Rosemary C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM DETECTION; BLOOD CULTURE; CLINICAL FEATURE; COMORBIDITY; COST BENEFIT ANALYSIS; DEMOGRAPHY; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MORTALITY; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; BACTEREMIA; EARLY DIAGNOSIS; GENETICS; GRAM-NEGATIVE BACTERIAL INFECTIONS; ISOLATION AND PURIFICATION; MIDDLE AGED; MOLECULAR DIAGNOSIS; PROCEDURES; SECONDARY PREVENTION; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BLOOD CULTURE; EARLY DIAGNOSIS; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; TIME FACTORS; YOUNG ADULT;

EID: 84976407322     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00376-16     Document Type: Article

References (31)

1. Elixhauser A, Friedman B, Stranges E. 2011. Septicemia in U. S. hospitals, 2009. Agency for Healthcare Research and Quality, Rockville, MD. http://www. hcup-us. ahrq. gov/reports/statbriefs/sb122. pdf.
2. Hill JT, Tran KD, Barton KL, Labreche MJ, Sharp SE. 2014. Evaluation of the nanosphere Verigene BC-GN assay for direct identification of gramnegative bacilli and antibiotic resistance markers from positive blood cultures and potential impact for more-rapid antibiotic interventions. J Clin Microbiol 52:3805-3807. http://dx. doi. org/10. 1128/JCM. 01537-14.
3. Kaye KS, Pogue JM. 2015. Infections caused by resistant gram-negative bacteria: epidemiology and management. Pharmacotherapy 35:949-962. http://dx. doi. org/10. 1002/phar. 1636.
4. Peleg AY, Hooper DC. 2010. Hospital-acquired infections due to gramnegative bacteria. NEngl J Med 362:1804-1813. http://dx. doi. org/10. 1056/NEJMra0904124.
5. Martinez RM, Bauerle ER, Fang FC, Butler-Wu SM. 2014. Evaluation of three rapid diagnostic methods for direct identification of microorganisms in positive blood cultures. J Clin Microbiol 52:2521-2529. http://dx.doi. org/10. 1128/JCM. 00529-14.
6. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. 2005. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 49:760-766. http://dx. doi. org/10. 1128/AAC. 49. 2. 760-766.2005.
7. Goff DA, Jankowski C, Tenover FC. 2012. Using rapid diagnostic tests to optimize antimicrobial selection in antimicrobial stewardship programs. Pharmacotherapy 32:677-687. http://dx. doi. org/10. 1002/j. 1875-9114.2012. 01137. x.
8. Sango A, McCarter YS, Johnson D, Ferreira J, Guzman N, Jankowski CA. 2013. Stewardship approach for optimizing antimicrobial therapy through use of a rapid microarray assay on blood cultures positive for Enterococcus species. J Clin Microbiol 51:4008-4011. http://dx. doi. org/10.1128/JCM. 01951-13.
9. Ward C, Stocker K, Begum J, Wade P, Ebrahimsa U, Goldenberg SD. 2015. Performance evaluation of the Verigene (Nanosphere) and Film Array (BioFire) molecular assays for identification of causative organisms in bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis 34: 487-496. http://dx. doi. org/10. 1007/s10096-014-2252-2.
10. Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA, Peterson LE, Musser JM. 2013. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 137:1247-1254. http://dx. doi. org/10. 5858/arpa. 2012-0651-O.A.
11. Aitken SL, Hemmige VS, Koo HL, Vuong NN, Lasco TM, Garey KW. 2015. Real-world performance of a microarray-based rapid diagnostic for Gram-positive bloodstream infections and potential utility for antimicrobial stewardship. Diagn Microbiol Infect Dis 81:4-8. http://dx. doi. org/10.1016/j. diagmicrobio. 2014. 09. 025.
12. Bauer KA, West JE, Balada-Llasat JM, Pancholi P, Stevenson KB, Goff DA. 2010. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis 51:1074-1080. http://dx. doi. org/10. 1086/656623.
13. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. 1985. APACHE II: a severity of disease classification system. Crit Care Med 13:818-829. http://dx. doi. org/10. 1097/00003246-198510000-00009.
14. Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing; 23rd informational supplement. CLSI M100-S23. Clinical and Laboratory Standards Institute, Wayne, P.A.
15. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18: 268-281. http://dx. doi. org/10. 1111/j. 1469-0691. 2011. 03570. x.
16. Siu GK, Chen JH, Ng TK, Lee RA, Fung KS, To SW, Wong BK, Cheung S, Wong IW, Tam MM, Lee SS, Yam WC. 2015. Performance evaluation of the Verigene Gram-positive and Gram-negative blood culture test for direct identification of bacteria and their resistance determinants from positive blood cultures in Hong Kong. PLoS One 10(10):e0139728. http://dx. doi. org/10. 1371/journal. pone. 0139728.
17. Bork JT, Leekha S, Heil EL, Zhao L, Badamas R, Johnson JK. 2015. Rapid testing using the Verigene Gram-negative blood culture nucleic acid test in combination with antimicrobial stewardship intervention against Gram-negative bacteremia. Antimicrob Agents Chemother 59: 1588-1595. http://dx. doi. org/10. 1128/AAC. 04259-14.
18. Tojo M, Fujita T, Ainoda Y, Nagamatsu M, Hayakawa K, Mezaki K, Sakurai A, Masui Y, Yazaki H, Takahashi H, Miyoshi-Akiyama T, Totsuka K, Kirikae T, Ohmagari N. 2014. Evaluation of an automated rapid diagnostic assay for detection of Gram-negative bacteria and their drug-resistance genes in positive blood cultures. PLoS One 9:e94064. http://dx. doi. org/10. 1371/journal. pone. 0094064.
19. Han E, Park DJ, Kim Y, Yu JK, Park KG, Park YJ. 2015. Rapid detection of Gram-negative bacteria and their drug resistance genes from positive blood cultures using an automated microarray assay. Diagn Microbiol Infect Dis 81:153-157. http://dx. doi. org/10. 1016/j.diagmicrobio. 2014. 10. 009.
20. Uno N, Suzuki H, Yamakawa H, Yamada M, Yaguchi Y, Notake S, Tamai K, Yanagisawa H, Misawa S, Yanagihara K. 2015. Multicenter evaluation of the Verigene Gram-negative blood culture nucleic acid test for rapid detection of bacteria and resistance determinants in positive blood cultures. Diagn Microbiol Infect Dis 83:344-348. http://dx. doi. org/10. 1016/j. diagmicrobio. 2015. 08. 004.
21. Suzuki H, Hitomi S, Yaguchi Y, Tamai K, Ueda A, Kamata K, Tokuda Y, Koganemaru H, Kurihara Y, Ishikawa H, Yanagisawa H, Yanagihara K. 2015. Prospective intervention study with a microarray-based, multiplexed, automated molecular diagnosis instrument (Verigene system) for the rapid diagnosis of bloodstream infections, and its impact on the clinical outcomes. J Infect Chemother 21:849-856. http://dx. doi. org/10. 1016/j. jiac. 2015. 08. 019.
22. Mancini N, Infurnari L, Ghidoli N, Valzano G, Clementi N, Burioni R, Clementi M. 2014. Potential impact of a microarray-based nucleic acid assay for rapid detection of Gram-negative bacteria and resistance markers in positive blood cultures. J Clin Microbiol 52:1242-1245. http://dx.doi. org/10. 1128/JCM. 00142-14.
23. Pogue JM, Mynatt RP, Marchaim D, Zhao JJ, Barr VO, Moshos J, Sunkara B, Chopra T, Chidurala S, Kaye KS. 2014. Automated alerts coupled with antimicrobial stewardship intervention lead to decreases in length of stay in patients with gram-negative bacteremia. Infect Control Hosp Epidemiol 35:132-138. http://dx. doi. org/10. 1086/674849.
24. Dodemont M, De Mendonca R, Nonhoff C, Roisin S, Denis O. 2014. Performance of the Verigene Gram-negative blood culture assay for rapid detection of bacteria and resistance determinants. J Clin Microbiol 52: 3085-3087. http://dx. doi. org/10. 1128/JCM. 01099-14.
25. Rosenblueth M, Martinez L, Silva J, Martinez-Romero E. 2004. Klebsiella variicola, a novel species with clinical and plant-associated isolates. Syst Appl Microbiol 27:27-35. http://dx. doi. org/10. 1078/0723-2020-00261.
26. Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Peterson LE, Musser JM. 2014. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gramnegative bacteremia. J Infect 69:216-225. http://dx. doi. org/10. 1016/j. jinf.2014. 05. 005.
27. She RC, Alrabaa S, Lee SH, Norvell M, Wilson A, Petti CA. 2015. Survey of physicians' perspectives and knowledge about diagnostic tests for bloodstream infections. PLoS One 10(3):e0121493. http://dx. doi. org/10.1371/journal. pone. 0121493.
28. Evans SR, Hujer AM, Jiang H, Hujer KM, Hall T, Marzan C, Jacobs MR, Sampath R, Ecker DJ, Manca C, Chavda K, Zhang P, Fernandez H, Chen L, Mediavilla JR, Hill CB, Perez F, Caliendo AM, Fowler VG, Jr, Chambers HF, Kreiswirth BN, Bonomo RA. 2016. Rapid molecular diagnostics, antibiotic treatment decisions, and developing approaches to inform empiric therapy: PRIMERS I and II. Clin Infect Dis 62:181-189. http://dx. doi. org/10. 1093/cid/civ837.
29. Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, Collins CD, Nagel JL. 2013. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis 57:1237-1245. http://dx. doi. org/10.1093/cid/cit498.
30. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. 2004. Bloodstream infections due to extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on anti microbial therapy. Antimicrob Agents Chemother 48:4574-4581. http://dx. doi. org/10. 1128/AAC. 48. 12. 4574-4581. 2004.
31. Cordery RJ, Roberts CH, Cooper SJ, Bellinghan G, Shetty N. 2008. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome. J Hosp Infect 68:108-115. http://dx. doi. org/10. 1016/j.jhin. 2007. 10. 011.